利尿剤の世界市場レポート 2025年

利尿剤の市場規模は、今後数年間で安定した成長が見込まれます。2029年にはCAGR3.5％で8億9,000万米ドルに成長します。予測期間の成長は、高血圧や心不全の罹患率の上昇、新興市場、政府の取り組み、予防医療への注力などに起因すると考えられます。予測期間の主な動向には、個別化医療、革新的な医薬品開発、遠隔医療と遠隔モニタリング、デジタルヘルスソリューションなどが含まれます。

利尿剤市場は、腎臓および腎臓疾患の有病率の増加により上昇基調にあります。腎臓が正常に機能しなくなると、尿の適切な流れを確保するため、一般に水薬として知られる利尿剤の需要が高まります。不健康でミネラルを多く含む食品の摂取を含むライフスタイルの変化が、腎臓疾患の増加に寄与しています。例えば、2024年5月、米国の公衆衛生機関である疾病対策予防センター（CDC）は、米国成人の約14％、約3,550万人が慢性腎臓病に罹患していると報告しました。このような腎臓および腎臓疾患の有病率の上昇が、利尿剤市場の成長を大きく促進しています。

利尿剤市場は、心臓疾患の罹患率の増加によって活性化すると予測されています。心臓疾患には、冠動脈疾患、心不全、不整脈など、心臓や血管に影響を及ぼすさまざまな病状が含まれます。利尿剤は、過剰な体液を減らし、血圧を下げ、心臓の負担を軽減することで、心血管系疾患の管理に極めて重要な役割を果たします。その結果、高血圧やうっ血性心不全といった疾患の全体的な管理が改善されます。例えば、2024年3月、英国の政府機関であるOffice for Health Improvement and Disparitiesのデータによると、2023年にはイングランドで186万人以上（3％）が冠動脈性心疾患（CHD）のGP診断を受けたことが明らかになりました。このような心臓疾患の発生率の上昇が、利尿剤市場の成長に寄与しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の利尿剤市場のPESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の利尿剤市場：成長率分析
• 世界の利尿剤市場の実績：規模と成長、2019～2024年
• 世界の利尿剤市場の予測：規模と成長、2024～2029年、2034年
• 世界の利尿剤総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の利尿剤市場：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• 浸透圧利尿剤
• 炭酸脱水酵素阻害剤
• ループ利尿剤
• チアジド・チアジド類似物質利尿剤
• アルドステロン拮抗薬
• 世界の利尿剤市場：流通チャネル別、実績と予測、2019～2024年、2024～2029年、2034年
• 病院薬局
• 独立系薬局
• 小売薬局
• ドラッグストア
• オンライン薬局
• 世界の利尿剤市場：用途別、実績と予測、2019～2024年、2024～2029年、2034年
• 高血圧
• 緑内障
• 心不全
• 腎臓結石
• 世界の利尿剤市場：浸透圧利尿剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• マンニトール
• グリセリン
• 尿素
• 世界の利尿剤市場：炭酸脱水酵素阻害剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• アセタゾラミド
• ドルゾラミド
• ブリンゾラミド
• 世界の利尿剤市場：ループ利尿剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• フロセミド
• ブメタニド
• トルセミド
• エタクリン酸
• 世界の利尿剤市場：チアジド・チアジド類似物質利尿剤のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• ヒドロクロロチアジド
• クロルタリドン
• インダパミド
• メトラゾン
• 世界の利尿剤市場：アルドステロン拮抗薬のサブセグメンテーション：タイプ別、実績と予測、2019～2024年、2024～2029年、2034年
• スピロノラクトン
• エプレレノン

第7章 地域別・国別分析

• 世界の利尿剤市場：地域別、実績と予測、2019～2024年、2024～2029年、2034年
• 世界の利尿剤市場：国別、実績と予測、2019～2024年、2024～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 利尿剤市場：競合情勢
• 利尿剤市場：企業プロファイル
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Meda Manufacturing GmbH Overview, Products and Services, Strategy and Financial Analysis
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Aton Pharma Inc.
• Boehringer Ingelheim International GmbH
• Novartis AG
• Teva Pharmaceutical Industries Ltd.
• Sanofi-aventis U.S. LLC
• Centaur Pharmaceuticals Pvt Ltd
• Validus Pharmaceuticals LLC
• Actavis Generics
• Paddock Laboratories LLC
• Perrigo Pharmaceutical Company
• H. Lundbeck Inc.
• Oak Pharmaceuticals Inc.
• Akron Pharmaceuticals Inc.
• Salix Pharmaceuticals Inc.
• Alembic Pharmaceuticals Limited

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 利尿剤市場2029：新たな機会を提供する国
• 利尿剤市場2029：新たな機会を提供するセグメント
• 利尿剤市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Diuretic drugs are medications that facilitate an increase in urine flow by reducing the concentration of sodium and chloride in the body. They aid in the removal of excess salt (sodium) and water, often referred to as 'water tablets.' Examples of diuretic drugs include Diuril, Microzide, and Indapamide.

The main categories of diuretics encompass osmotic diuretics, carbonic anhydrase inhibitors, loop diuretics, thiazides and thiazide-like diuretics, and aldosterone antagonists. Osmotic diuretics prevent the reabsorption of water and sodium and are typically administered intravenously as pharmacologically inactive compounds. They are employed in the treatment of conditions like hypertension, glaucoma, heart failure, and kidney stones. These diuretics are distributed through various channels, including hospital pharmacies, independent pharmacies, retail pharmacies, drug stores, and online pharmacies.

The diuretics market research report is one of a series of new reports from The Business Research Company that provides diuretics market statistics, including diuretics industry global market size, regional shares, competitors with a diuretics market share, detailed diuretics market segments, market trends and opportunities, and any further data you may need to thrive in the diuretics industry. This diuretics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The diuretics market size has grown steadily in recent years. It will grow from $0.74 billion in 2024 to $0.77 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, clinical guidelines, pharmaceutical innovation, increase in obesity.

The diuretics market size is expected to see steady growth in the next few years. It will grow to $0.89 billion in 2029 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to rising incidence of hypertension and heart failure, emerging markets, government initiatives, focus on preventive healthcare. Major trends in the forecast period include personalized medicine, innovative drug development, telehealth and remote monitoring, digital health solutions.

The diuretics market is on an upward trajectory due to the increasing prevalence of renal and kidney disorders. When the kidneys fail to function properly, there is a heightened demand for diuretic drugs, commonly known as water pills, to ensure the proper flow of urine. Lifestyle changes, including the consumption of unhealthy, mineral-rich foods, are contributing to the rise in kidney disorders. For example, in May 2024, the Centers for Disease Control and Prevention (CDC), a US-based public health agency, reported that approximately 14% of U.S. adults, equating to around 35.5 million individuals, are affected by chronic kidney disease. This rising prevalence of renal and kidney disorders is significantly driving the growth of the diuretics market.

The diuretics market is anticipated to be fueled by the increasing incidence of cardiac disorders. Cardiac disorders encompass a range of medical conditions affecting the heart and blood vessels, including coronary artery disease, heart failure, and arrhythmias. Diuretics play a pivotal role in managing cardiovascular diseases by reducing excess bodily fluids, lowering blood pressure, and easing the workload on the heart. This, in turn, improves the overall management of conditions such as hypertension and congestive heart failure. For example, in March 2024, data from the Office for Health Improvement and Disparities, a UK-based government agency, revealed that in 2023, over 1.86 million people (3%) in England had received a GP diagnosis of coronary heart disease (CHD). This rise in the incidence of cardiac disorders is contributing to the growth of the diuretics market.

Major companies in the diuretics market are focusing on developing innovative products, such as prescription medications, to enhance treatment efficacy and minimize side effects for patients with conditions like hypertension and heart failure. Prescription medications are those that require a doctor's prescription, ensuring their appropriate use under professional supervision for specific medical conditions. For example, in January 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched a generic version of the diuretic Bumetanide Injection for treating fluid retention and swelling associated with conditions like congestive heart failure. This product is available in two formulations: 1 mg/4 mL single-dose vials and 2.5 mg/10 mL multi-dose vials, both containing a concentration of 0.25 mg/mL. The injection is used to effectively treat edema caused by conditions such as congestive heart failure, liver disease, and kidney disease, promoting increased urine production to alleviate symptoms such as swelling and difficulty breathing.

Major companies are introducing innovative products like FUROSCIX to expand their global presence and gain a competitive edge. FUROSCIX is a subcutaneous furosemide injection that offers an alternative method for administering diuretic medication to manage fluid overload in patients with heart failure. For instance, scPharmaceuticals Inc. announced FDA approval for FUROSCIX in October 2022, specifically for treating congestion caused by fluid overload in adults with New York Heart Association Class II/III chronic heart failure. FUROSCIX provides at-home IV-equivalent diuresis through the FUROSCIX Infusor and is the first and only FDA-approved subcutaneous loop diuretic.

In November 2022, Novo Integrated Sciences Inc., a healthcare company, and Clinical Consultants International LLC, a hospital consulting firm, entered into a consulting agreement with Sarfez Pharmaceuticals Inc. for an FDA-approved edema treatment targeting patients with heart failure and renal disease. Utilizing their extensive network of hospitals, physicians, and independent pharmacies, CCI and the Novo team will collaborate with Sarfez on the marketing and distribution of the commercially available SOAANZ treatment. Sarfez Pharmaceuticals Inc. is a pharmaceutical research and development company.

Major companies operating in the diuretics market include Merck & Co. Inc., Meda Manufacturing GmbH, Pfizer Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Aton Pharma Inc., Boehringer Ingelheim International GmbH, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi-aventis U.S. LLC, Centaur Pharmaceuticals Pvt Ltd., Validus Pharmaceuticals LLC, Actavis Generics, Paddock Laboratories LLC, Perrigo Pharmaceutical Company, H. Lundbeck Inc., Oak Pharmaceuticals Inc., Akron Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Aurobindo Pharma Limited, IPCA Laboratories Limited, Jubilant Cadista Pharmaceuticals Limited, Mylan N.V., Princeton Laboratories Inc., Sciegen Pharma Limited, Unichem Laboratories Limited, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Company, Cipla Ltd., F Hoffmann-La Roche Ltd., Fresenius Kabi AG, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.

North America was the largest region in the diuretics market in 2024. The Middle East is expected to be the fastest-growing region in the diuretics market during the forecast period. The regions covered in the diuretics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the diuretics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada

The diuretics market consists of sales of diuril, microzide, and indapamide. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Diuretics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on diuretics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for diuretics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The diuretics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Osmotic Diuretics; Carbonic Anhydrase Inhibitors; Loop Diuretics; Thiazides And Thiazide-Like Diuretics; Aldosterone Antagonists
• 2) By Distribution: Hospital Pharmacies; Independent Pharmacies; Retail Pharmacies; Drug Stores; Online Pharmacies
• 3) By Application: Hypertension; Glaucoma; Heart Failure; Kidney Stones
• Subsegments:
• 1) By Osmotic Diuretics: Mannitol; Glycerin; Urea
• 2) By Carbonic Anhydrase Inhibitors: Acetazolamide; Dorzolamide; Brinzolamide
• 3) By Loop Diuretics: Furosemide; Bumetanide; Torsemide; Ethacrynic Acid
• 4) By Thiazides And Thiazide-Like Diuretics: Hydrochlorothiazide; Chlorthalidone; Indapamide; Metolazone
• 5) By Aldosterone Antagonists: Spironolactone; Eplerenone
• Companies Mentioned: Merck & Co. Inc.; Meda Manufacturing GmbH; Pfizer Inc.; GlaxoSmithKline plc.; F. Hoffmann-La Roche AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Diuretics Market Characteristics

3. Diuretics Market Trends And Strategies

4. Diuretics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Diuretics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Diuretics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Diuretics Market Growth Rate Analysis
• 5.4. Global Diuretics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Diuretics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Diuretics Total Addressable Market (TAM)

6. Diuretics Market Segmentation

• 6.1. Global Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Osmotic Diuretics
• Carbonic Anhydrase Inhibitors
• Loop Diuretics
• Thiazides And Thiazide-Like Diuretics
• Aldosterone Antagonists
• 6.2. Global Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Pharmacies
• Independent Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
• 6.3. Global Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hypertension
• Glaucoma
• Heart Failure
• Kidney Stones
• 6.4. Global Diuretics Market, Sub-Segmentation Of Osmotic Diuretics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mannitol
• Glycerin
• Urea
• 6.5. Global Diuretics Market, Sub-Segmentation Of Carbonic Anhydrase Inhibitors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acetazolamide
• Dorzolamide
• Brinzolamide
• 6.6. Global Diuretics Market, Sub-Segmentation Of Loop Diuretics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Furosemide
• Bumetanide
• Torsemide
• Ethacrynic Acid
• 6.7. Global Diuretics Market, Sub-Segmentation Of Thiazides And Thiazide-Like Diuretics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hydrochlorothiazide
• Chlorthalidone
• Indapamide
• Metolazone
• 6.8. Global Diuretics Market, Sub-Segmentation Of Aldosterone Antagonists, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spironolactone
• Eplerenone

7. Diuretics Market Regional And Country Analysis

• 7.1. Global Diuretics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Diuretics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Diuretics Market

• 8.1. Asia-Pacific Diuretics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Diuretics Market

• 9.1. China Diuretics Market Overview
• 9.2. China Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Diuretics Market

• 10.1. India Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Diuretics Market

• 11.1. Japan Diuretics Market Overview
• 11.2. Japan Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Diuretics Market

• 12.1. Australia Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Diuretics Market

• 13.1. Indonesia Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Diuretics Market

• 14.1. South Korea Diuretics Market Overview
• 14.2. South Korea Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Diuretics Market

• 15.1. Western Europe Diuretics Market Overview
• 15.2. Western Europe Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Diuretics Market

• 16.1. UK Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Diuretics Market

• 17.1. Germany Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Diuretics Market

• 18.1. France Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Diuretics Market

• 19.1. Italy Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Diuretics Market

• 20.1. Spain Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Diuretics Market

• 21.1. Eastern Europe Diuretics Market Overview
• 21.2. Eastern Europe Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Diuretics Market

• 22.1. Russia Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Diuretics Market

• 23.1. North America Diuretics Market Overview
• 23.2. North America Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Diuretics Market

• 24.1. USA Diuretics Market Overview
• 24.2. USA Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Diuretics Market

• 25.1. Canada Diuretics Market Overview
• 25.2. Canada Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Diuretics Market

• 26.1. South America Diuretics Market Overview
• 26.2. South America Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Diuretics Market

• 27.1. Brazil Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Diuretics Market

• 28.1. Middle East Diuretics Market Overview
• 28.2. Middle East Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Diuretics Market

• 29.1. Africa Diuretics Market Overview
• 29.2. Africa Diuretics Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Diuretics Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Diuretics Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Diuretics Market Competitive Landscape And Company Profiles

• 30.1. Diuretics Market Competitive Landscape
• 30.2. Diuretics Market Company Profiles
  • 30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Meda Manufacturing GmbH Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GlaxoSmithKline plc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

31. Diuretics Market Other Major And Innovative Companies

• 31.1. Aton Pharma Inc.
• 31.2. Boehringer Ingelheim International GmbH
• 31.3. Novartis AG
• 31.4. Teva Pharmaceutical Industries Ltd.
• 31.5. Sanofi-aventis U.S. LLC
• 31.6. Centaur Pharmaceuticals Pvt Ltd
• 31.7. Validus Pharmaceuticals LLC
• 31.8. Actavis Generics
• 31.9. Paddock Laboratories LLC
• 31.10. Perrigo Pharmaceutical Company
• 31.11. H. Lundbeck Inc.
• 31.12. Oak Pharmaceuticals Inc.
• 31.13. Akron Pharmaceuticals Inc.
• 31.14. Salix Pharmaceuticals Inc.
• 31.15. Alembic Pharmaceuticals Limited

32. Global Diuretics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Diuretics Market

34. Recent Developments In The Diuretics Market

35. Diuretics Market High Potential Countries, Segments and Strategies

• 35.1 Diuretics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Diuretics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Diuretics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer